From: The effect of azithromycin on sputum inflammatory markers in bronchiectasis
AZM | Placebo | |||||
---|---|---|---|---|---|---|
Baseline (n = 25) | Exacerbation (n = 9) | p-value | Baseline (n = 29) | Exacerbation (n = 20) | p-value | |
MPO (ug) | 81.4 (203.1) | 706.9 (1718.2) | 0.068 | 53.3 (270.2) | 222.3 (2260.1) | 0.015 |
ECP (ug) | 4.0 (9.0) | 27.1 (151.2) | 0.068 | 3.6 (9) | 9.3 (67.8) | 0.015 |
IP-10 (pg) | 43 (167.6) | 362.6 (1299) | 0.144 | 76.3 (149.2) | 108.4 (1270.7) | 0.125 |
MIP-1β (ng) | 4.3 (6.3) | 54.8 (132.5) | 0.144 | 7.1 (14.4) | 19,688.2 (83,389.0) | 0.020 |
VEGF (pg) | 1443.3 (3936.9) | 14,802.6 (29,729.1) | 0.144 | 1700.1 (3985.2) | 3990.8 (41,378.1) | 0.078 |
TNF-α (pg) | 175.7 (1025) | 3629.5 (22,676.3) | 0.068 | 129.9 (1841) | 2287.0 (7732.4) | 0.020 |
IL-1RA (pg) | 617.2 (2112.2) | 2760.9 (3649.9) | 0.465 | 606.7 (1578) | 1867.5 (17,356.4) | 0.020 |
IL-21 (pg) | 1.8 (47) | 306.2 (680.1) | 0.109 | 8.4 (90) | 59.7 (1392.0) | 0.046 |
IL-8 (ng) | 25 (101.4) | 148 (407.5) | 0.068 | 22.1 (70.3) | 80.9 (239.4) | 0.053 |
IL-1β (ng) | 6 (14.7) | 72.8 (140) | 0.068 | 7.5 (41.8) | 39 (392.2) | 0.012 |
IL-6 (pg) | 0 (922.3) | 290.5 (1705.2) | 0.109 | 63.9 (504.8) | 29.2 (809) | 0.937 |
GCSF (pg) | 0 (129.9) | 0 (992.9) | 0.180 | 0 (26.1) | 0 (35.6) | 0.173 |
GRO-α (pg) | 9 (418.4) | 155.8 (1753.3) | 1.000 | 17 (170) | 0 (289.7) | 0.594 |
IL-1α (pg) | 286.8 (717.4) | 1829.7 (3282.2) | 0.068 | 285.3 (1071.9) | 1069.1 (3207.4) | 0.015 |
MIP-3α (pg) | 0 (236) | 101 (1754.3) | 0.180 | 0 (64) | 67.6 (215.4) | 0.463 |
MMP-9 (ng) | 194.9 (328.5) | 851.8 (2389.9) | 0.144 | 177.1 (375.1) | 337 (2311.3) | 0.061 |